Financhill
Buy
68

USB Quote, Financials, Valuation and Earnings

Last price:
$43.65
Seasonality move :
0.76%
Day range:
$43.18 - $43.78
52-week range:
$35.18 - $53.98
Dividend yield:
4.55%
P/E ratio:
10.83x
P/S ratio:
2.48x
P/B ratio:
1.28x
Volume:
6.4M
Avg. volume:
8.1M
1-year change:
12.09%
Market cap:
$68.2B
Revenue:
$27.3B
EPS (TTM):
$4.04

Earnings Data

Next earnings date for USB
Jul 17
2025
Most recent earnings per share
$1.03
Beat by $0.06
(Apr 16/2025)
Consensus Estimate
$0.97
(Apr 16/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

USB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
07/17/2025 Q2 $7.1B -- -- $1.07 --
04/16/2025 Q1 $6.9B $6.9B $1.03 $0.97 $0.06
01/16/2025 Q4 $7B $7B $1.01 $1.05 -$0.04
10/16/2024 Q3 $6.9B $6.8B $1.03 $0.99 $0.04
07/17/2024 Q2 $6.8B $6.8B $0.97 $0.95 $0.02
04/17/2024 Q1 $6.7B $6.7B $0.78 $0.88 -$0.10
01/17/2024 Q4 $6.9B $6.7B $0.49 $0.91 -$0.42
10/18/2023 Q3 -- -- $0.91 $1.01 -$0.10
07/19/2023 Q2 -- -- $0.84 $1.10 -$0.26
04/19/2023 Q1 -- -- $1.04 $1.12 -$0.08
01/25/2023 Q4 -- -- $0.57 $1.14 -$0.57
10/14/2022 Q3 -- -- $1.16 $1.16 $0.00
07/15/2022 Q2 -- -- $0.99 $1.07 -$0.08
04/14/2022 Q1 -- -- $0.99 $0.94 $0.05
01/19/2022 Q4 -- -- $1.07 $1.10 -$0.03
10/14/2021 Q3 -- -- $1.30 $1.16 $0.14
07/15/2021 Q2 -- -- $1.28 $1.13 $0.15
04/15/2021 Q1 -- -- $1.45 $0.96 $0.49
01/15/2021 Q4 -- -- $0.95 $0.94 $0.01
10/14/2020 Q3 -- -- $0.99 $0.91 $0.08
07/15/2020 Q2 -- -- $0.41 $0.40 $0.01
04/15/2020 Q1 -- -- $0.72 $0.81 -$0.09
01/15/2020 Q4 -- -- $0.90 $1.09 -$0.19
10/16/2019 Q3 -- -- $1.15 $1.11 $0.04
07/17/2019 Q2 -- -- $1.09 $1.07 $0.02
04/17/2019 Q1 -- -- $1.00 $1.00 -$0.00
01/16/2019 Q4 -- -- $1.10 $1.06 $0.04
10/17/2018 Q3 -- -- $1.06 $1.04 $0.02
07/18/2018 Q2 -- -- $1.02 -- --
04/18/2018 Q1 -- -- $0.96 -- --
01/17/2018 Q4 -- -- $0.97 -- --
10/18/2017 Q3 -- -- $0.88 -- --
07/19/2017 Q2 -- -- $0.85 -- --
04/19/2017 Q1 -- -- $0.82 -- --
01/18/2017 Q4 -- -- $0.82 -- --
10/19/2016 Q3 -- -- $0.84 -- --
07/15/2016 Q2 -- -- $0.83 -- --
04/20/2016 Q1 -- -- $0.76 -- --
01/15/2016 Q4 -- -- $0.80 -- --
10/15/2015 Q3 -- -- $0.81 -- --
07/15/2015 Q2 -- -- $0.80 -- --

U.S. Bancorp Earnings Questions

  • How Much did U.S. Bancorp Generate in Revenue Last Quarter?

    U.S. Bancorp reported $6.9B worth of top line sales in its most recent quarter.

  • Did U.S. Bancorp Beat Earnings Last Quarter?

    U.S. Bancorp announced earnings per share of $1.03 which represents a beat of analyst forecast a $0.97 per share.

  • Is U.S. Bancorp Profitable?

    U.S. Bancorp reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for U.S. Bancorp EPS Next Year?

    U.S. Bancorp's earnings are forecast to grow from $3.79 per share to $3.91 per share next year representing an increase of 14.27%.

  • When is U.S. Bancorp's Earnings Date?

    U.S. Bancorp's next earnings date is July 17, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Dell Stock Be in 5 Years?
Where Will Dell Stock Be in 5 Years?

So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…

Where Will Cameco Stock Be in 5 Years?
Where Will Cameco Stock Be in 5 Years?

Cameco (NYSE: CCJ) isn’t exactly the kind of stock you…

Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth
Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth

Microsoft (NASDAQ:MSFT) has been among the top growth stocks of…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 47x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
84
SBET alert for May 30

SharpLink Gaming [SBET] is down 10.77% over the past day.

Buy
55
RGC alert for May 30

Regencell Bioscience Holdings [RGC] is up 11.34% over the past day.

Buy
73
CTEV alert for May 30

Claritev [CTEV] is up 6.32% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock